Summary/Abstract:
This chapter discusses the background to the need for pharmacovigilance and describes in detail two of the main mechanisms by which this is studied in the UK: the Yellow Card Spontaneous Reporting Scheme, and Prescription-Event Monitoring. A brief discussion of the complementarity of the two systems concludes this chapter.